WallStreetZenWallStreetZen

NASDAQ: PLUR
Pluri Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their PLUR stock forecasts and price targets.

Forecast return on equity

Is PLUR forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is PLUR forecast to generate an efficient return on assets?

Company
-80.25%
Industry
-21.63%
PLUR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PLUR earnings per share forecast

What is PLUR's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.94

PLUR revenue forecast

What is PLUR's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$10.4M+862.84%
PLUR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PLUR revenue growth forecast

How is PLUR forecast to perform vs Biotechnology companies and vs the US market?

Company
862.84%
Industry
21.45%
Market
22.03%
PLUR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PLUR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PLUR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PLUR$1.56N/AN/A
CTXR$0.63$5.00+691.14%Strong Buy
JSPR$0.62$3.83+517.23%Hold
LPCN$2.11N/AN/A
NCEL$3.36$23.00+584.32%Strong Buy
View Top Biotech Stocks

Pluri Stock Forecast FAQ

What is PLUR's earnings growth forecast for 2027-2027?

(NASDAQ: PLUR) Pluri's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 108.49%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,398.91%.

Pluri's earnings in 2026 is -$25,539,000.

In 2027, PLUR is forecast to generate -$20,910,140 in earnings, with the lowest earnings forecast at -$20,090,135 and the highest earnings forecast at -$21,525,144.

If you're new to stock investing, here's how to buy Pluri stock.

What is PLUR's revenue growth forecast for 2027-2027?

(NASDAQ: PLUR) Pluri's forecast annual revenue growth rate of 862.84% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 21.45%, and it is also forecast to beat the US market's average forecast revenue growth rate of 22.03%.

Pluri's revenue in 2026 is $1,079,000.

In 2027, PLUR is forecast to generate $112,092,593 in revenue, with the lowest revenue forecast at $107,690,459 and the highest revenue forecast at $115,383,405.

What is PLUR's forecast return on assets (ROA) for 2027-2027?

(NASDAQ: PLUR) forecast ROA is -80.25%, which is lower than the forecast US Biotechnology industry average of -21.63%.

What is PLUR's Earnings Per Share (EPS) forecast for 2027-2027?

(NASDAQ: PLUR) Pluri's current Earnings Per Share (EPS) is -$2.91. In 2027, PLUR's EPS is forecast to hit -$1.94 (min: -$1.86, max: -$2.00).

What is PLUR's forecast return on equity (ROE) for 2027-2027?

(NASDAQ: PLUR) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.